Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved?

Redox Biology

Volumn 6, Issue , 2015, Pages 372-385

  Görlach, Agnes ^a,b   Dimova, Elitsa Y ^c   Petry, Andreas ^a,b   Martínez Ruiz, Antonio ^d   Hernansanz Agustín, Pablo ^d,e   Rolo, Anabela P ^f   Palmeira, Carlos M ^f   Kietzmann, Thomas ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c UNIVERSITY OF OULU   (Finland)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^f UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Diabetes; Diets; Diseases; Free radicals; Hypoxia; Metabolism; Mitochondria; Obesity; Oxygen

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OXOGLUTARATE DEHYDROGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; POLYPHENOL; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN TYROSINE PHOSPHATASE; PYRUVATE DEHYDROGENASE; QUERCETIN; RAF PROTEIN; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SOS PROTEIN; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; UNINDEXED DRUG; NUCLEOCYTOPLASMIC TRANSPORT PROTEIN; NUTF2 PROTEIN, HUMAN; PLACENTA PROTEIN;

CARDIOVASCULAR DISEASE; CELL MEMBRANE; CHRONIC DISEASE; DIET; DRUG EFFECT; DRUG MEGADOSE; ENDOPLASMIC RETICULUM; HUMAN; HYPOXIA; INSULIN RESISTANCE; LYSOSOME; METABOLIC DISORDER; MITOCHONDRION; NEOPLASM; NONHUMAN; NUTRITION; OVERNUTRITION; OXIDATIVE STRESS; PEROXISOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ATHEROSCLEROSIS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL REQUIREMENT; OBESITY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASMS; NF-KAPPA B; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; NUTRITIONAL REQUIREMENTS; OBESITY; OXIDATIVE STRESS; PREGNANCY PROTEINS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84940472278     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2015.08.016     Document Type: Review

References (247)

1. Wood P.M. The potential diagram for oxygen at pH 7. Biochem. J. 1988, 253:287-289.
2. Winterbourn C.C. Reconciling the chemistry and biology of reactive oxygen species. Nat. Chem. Biol. 2008, 4:278-286.
3. Kietzmann T., Gorlach A. Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin. Cell. Dev. Biol. 2005, 16:474-486.
4. Ceriello A., Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 2004, 24:816-823.
5. Ziech D., Franco R., Pappa A., Panayiotidis M.I. Reactive oxygen species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis. Mutat. Res. 2011, 711:167-173.
6. Gupta S.C., Hevia D., Patchva S., Park B., Koh W., et al. Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxid. Redox Signal. 2012, 16:1295-1322.
7. Dimova E.Y., Samoylenko A., Kietzmann T. Oxidative stress and hypoxia: implications for plasminogen activator inhibitor-1 expression. Antioxid. Redox Signal. 2004, 6:777-791.
8. Sankhla M., Sharma T.K., Mathur K., Rathor J.S., Butolia V., et al. Relationship of oxidative stress with obesity and its role in obesity induced metabolic syndrome. Clin. Lab. 2012, 58:385-392.
9. Chrysohoou C., Panagiotakos D.B., Pitsavos C., Skoumas J., Krinos X., et al. Long-term fish consumption is associated with protection against arrhythmia in healthy persons in a Mediterranean region--the ATTICA study. Am. J. Clin. Nutr. 2007, 85:1385-1391.
10. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
11. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004, 114:1752-1761.
12. Roberts C.K., Sindhu K.K. Oxidative stress and metabolic syndrome. Life Sci. 2009, 84:705-712.
13. Kaludercic N., Deshwal S., Di Lisa F. Reactive oxygen species and redox compartmentalization. Front. Physiol. 2014, 5:285.
14. Ushio-Fukai M. Localizing NADPH oxidase-derived ROS. Sci. STKE 2006, 2006:re8.
15. Geiszt M., Leto T.L. The Nox family of NAD(P)H oxidases: host defense and beyond. J. Biol. Chem. 2004, 279:51715-51718.
16. Babior B.M., Lambeth J.D., Nauseef W. The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 2002, 397:342-344.
17. De Deken X., Wang D., Many M.C., Costagliola S., Libert F., et al. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J. Biol. Chem. 2000, 275:23227-23233.
18. Suh Y.A., Arnold R.S., Lassegue B., Shi J., Xu X., et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999, 401:79-82.
19. Cheng G., Cao Z., Xu X., van Meir E.G., Lambeth J.D. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 2001, 269:131-140.
20. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007, 87:245-313.
21. Rokutan K., Kawahara T., Kuwano Y., Tominaga K., Nishida K., et al. Nox enzymes and oxidative stress in the immunopathology of the gastrointestinal tract. Semin. Immunopathol. 2008, 30:315-327.
22. Cui X.L., Brockman D., Campos B., Myatt L. Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia. Placenta 2006, 27:422-431.
23. Uchizono Y., Takeya R., Iwase M., Sasaki N., Oku M., et al. Expression of isoforms of NADPH oxidase components in rat pancreatic islets. Life Sci. 2006, 80:133-139.
24. Miller F.J., Filali M., Huss G.J., Stanic B., Chamseddine A., et al. Cytokine activation of nuclear factor kappa B in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3. Circ. Res. 2007, 101:663-671.
25. Hilenski L.L., Clempus R.E., Quinn M.T., Lambeth J.D., Griendling K.K. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2004, 24:677-683.
26. Petry A., Weitnauer M., Gorlach A. Receptor activation of NADPH oxidases. Antioxid. Redox Signal. 2010, 13:467-487.
27. Geiszt M., Kopp J.B., Varnai P., Leto T.L. Identification of renox, an NAD(P)H oxidase in kidney. Proc. Natl. Acad. Sci. USA 2000, 97:8010-8014.
28. Carmona-Cuenca I., Herrera B., Ventura J.J., Roncero C., Fernandez M., et al. EGF blocks NADPH oxidase activation by TGF-beta in fetal rat hepatocytes, impairing oxidative stress, and cell death. J. Cell. Physiol. 2006, 207:322-330.
29. Ago T., Kitazono T., Ooboshi H., Iyama T., Han Y.H., et al. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 2004, 109:227-233.
30. Cucoranu I., Clempus R., Dikalova A., Phelan P.J., Ariyan S., et al. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res. 2005, 97:900-907.
31. Petry A., Djordjevic T., Weitnauer M., Kietzmann T., Hess J., et al. NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid. Redox Signal. 2006, 8:1473-1484.
32. Brown D.I., Griendling K.K. Nox proteins in signal transduction. Free Radic. Biol. Med. 2009, 47:1239-1253.
33. BelAiba R.S., Djordjevic T., Petry A., Diemer K., Bonello S., et al. NOX5 variants are functionally active in endothelial cells. Free Radic. Biol. Med. 2007, 42:446-459.
34. De Deken X., Wang D., Dumont J.E., Miot F. Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system. Exp. Cell Res. 2002, 273:187-196.
35. Fischer H. Mechanisms and function of DUOX in epithelia of the lung. Antioxid. Redox Signal. 2009, 11:2453-2465.
36. Ha E.M., Oh C.T., Bae Y.S., Lee W.J. A direct role for dual oxidase in Drosophila gut immunity. Science 2005, 310:847-850.
37. Tirone F., Cox J.A. NADPH oxidase 5 (NOX5) interacts with and is regulated by calmodulin. FEBS Lett. 2007, 581:1202-1208.
38. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417:1-13.
39. Brand M.D. The sites and topology of mitochondrial superoxide production. Exp. Gerontol. 2010, 45:466-472.
40. Vina J., Gambini J., Lopez-Grueso R., Abdelaziz K.M., Jove M., et al. Females live longer than males: role of oxidative stress. Curr. Pharm. Des. 2011, 17:3959-3965.
41. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790.
42. Cardoso A.R., Chausse B., da Cunha F.M., Luevano-Martinez L.A., Marazzi T.B., et al. Mitochondrial compartmentalization of redox processes. Free Radic. Biol. Med. 2012, 52:2201-2208.
43. Quinlan C.L., Goncalves R.L., Hey-Mogensen M., Yadava N., Bunik V.I., et al. The 2-oxoacid dehydrogenase complexes in mitochondria can produce superoxide/hydrogen peroxide at much higher rates than complex I. J. Biol. Chem. 2014, 289:8312-8325.
44. Fisher-Wellman K.H., Gilliam L.A., Lin C.T., Cathey B.L., Lark D.S., et al. Mitochondrial glutathione depletion reveals a novel role for the pyruvate dehydrogenase complex as a key H2O2-emitting source under conditions of nutrient overload. Free Radic. Biol. Med. 2013, 65:1201-1208.
45. Tretter L., Adam-Vizi V. Generation of reactive oxygen species in the reaction catalyzed by alpha-ketoglutarate dehydrogenase. J. Neurosci. 2004, 24:7771-7778.
46. Starkov A.A., Fiskum G., Chinopoulos C., Lorenzo B.J., Browne S.E., et al. Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J. Neurosci. 2004, 24:7779-7788.
47. Giorgio M., Migliaccio E., Orsini F., Paolucci D., Moroni M., et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005, 122:221-233.
48. Gorlach A., Klappa P., Kietzmann T. The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid. Redox Signal. 2006, 8:1391-1418.
49. Janiszewski M., Lopes L.R., Carmo A.O., Pedro M.A., Brandes R.P., et al. Regulation of NAD(P)H oxidase by associated protein disulfide isomerase in vascular smooth muscle cells. J. Biol. Chem. 2005, 280:40813-40819.
50. Liu Q., Berchner-Pfannschmidt U., Moller U., Brecht M., Wotzlaw C., et al. A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression. Proc. Natl. Acad. Sci. USA 2004, 101:4302-4307.
51. Nohl H., Gille L. The bifunctional activity of ubiquinone in lysosomal membranes. Biogerontology 2002, 3:125-131.
52. Kurz T., Eaton J.W., Brunk U.T. Redox activity within the lysosomal compartment: implications for aging and apoptosis. Antioxid. Redox Signal. 2010, 13:511-523.
53. Antonenkov V.D., Grunau S., Ohlmeier S., Hiltunen J.K. Peroxisomes are oxidative organelles. Antioxid. Redox Signal. 2010, 13:525-537.
54. Schrader M., Fahimi H.D. Peroxisomes and oxidative stress. Biochim. Biophys. Acta 2006, 1763:1755-1766.
55. Maehly A.C., Chance B. The assay of catalases and peroxidases. Methods Biochem. Anal. 1954, 1:357-424.
56. Wiseman H., Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 1996, 313(Pt 1):17-29.
57. Marnett L.J. Oxy radicals, lipid peroxidation and DNA damage. Toxicology 2002, 181-182:219-222.
58. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem.-Biol. Interact. 2006, 160:1-40.
59. Stadtman E.R. Role of oxidant species in aging. Curr. Med. Chem. 2004, 11:1105-1112.
60. Carew J.S., Huang P. Mitochondrial defects in cancer. Mol. Cancer 2002, 1:9.
61. Tamori A., Nishiguchi S., Nishikawa M., Kubo S., Koh N., et al. Correlation between clinical characteristics and mitochondrial d-loop DNA mutations in hepatocellular carcinoma. J. Gastroenterol. 2004, 39:1063-1068.
62. Liu V.W., Shi H.H., Cheung A.N., Chiu P.M., Leung T.W., et al. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res. 2001, 61:5998-6001.
63. Tan D.J., Bai R.K., Wong L.J. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 2002, 62:972-976.
64. Lievre A., Chapusot C., Bouvier A.M., Zinzindohoue F., Piard F., et al. Clinical value of mitochondrial mutations in colorectal cancer. J. Clin. Oncol. 2005, 23:3517-3525.
65. Takeuchi H., Fujimoto A., Hoon D.S. Detection of mitochondrial DNA alterations in plasma of malignant melanoma patients. Ann. N. Y. Acad. Sci. 2004, 1022:50-54.
66. Mikhed Y., Gorlach A., Knaus U.G., Daiber A. Redox regulation of genome stability by effects on gene expression, epigenetic pathways and DNA damage/repair. Redox Biol. 2015, 5:275-289.
67. Franco R., Schoneveld O., Georgakilas A.G., Panayiotidis M.I. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett. 2008, 266:6-11.
68. Chia N., Wang L., Lu X., Senut M.C., Brenner C., et al. Hypothesis: environmental regulation of 5-hydroxymethylcytosine by oxidative stress. Epigenetics 2011, 6:853-856.
69. Turk P.W., Laayoun A., Smith S.S., Weitzman S.A. DNA adduct 8-hydroxyl-2'-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis 1995, 16:1253-1255.
70. Kapahi P., Boulton M.E., Kirkwood T.B. Positive correlation between mammalian life span and cellular resistance to stress. Free Radic. Biol. Med. 1999, 26:495-500.
71. Vurusaner B., Poli G., Basaga H. Tumor suppressor genes and ROS: complex networks of interactions. Free Radic. Biol. Med. 2012, 52:7-18.
72. Morgan M.J., Liu Z.G. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 2011, 21:103-115.
73. Kristal A.R., Arnold K.B., Neuhouser M.L., Goodman P., Platz E.A., et al. Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial. Am. J. Epidemiol. 2010, 172:566-577.
74. Comba A., Lin Y.H., Eynard A.R., Valentich M.A., Fernandez-Zapico M.E., et al. Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors. Cancer Metastasis Rev. 2011, 30:325-342.
75. Yao H., Ashihara E., Maekawa T. Targeting the Wnt/beta-catenin signaling pathway in human cancers. Expert Opin. Ther. Targets 2011, 15:873-887.
76. Lauth M. RAS and Hedgehog-partners in crime. Front. Biosci. (Landmark edition) 2011, 16:2259-2270.
77. Ray P.D., Huang B.W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 2012, 24:981-990.
78. Badid N., Ahmed F.Z., Merzouk H., Belbraouet S., Mokhtari N., et al. Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer. Pathol. Oncol. Res. 2010, 16:159-167.
79. Basnet P., Skalko-Basnet N. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 2011, 16:4567-4598.
80. Knebel A., Rahmsdorf H.J., Ullrich A., Herrlich P. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J. 1996, 15:5314-5325.
81. Lander H.M., Hajjar D.P., Hempstead B.L., Mirza U.A., Chait B.T., et al. A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. J. Biol. Chem. 1997, 272:4323-4326.
82. McCubrey J.A., Steelman L.S., Chappell W.H., Abrams S.L., Wong E.W., et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim. Biophys. Acta 2007, 1773:1263-1284.
83. Chan D.W., Liu V.W., Tsao G.S., Yao K.M., Furukawa T., et al. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells. Carcinogenesis 2008, 29:1742-1750.
84. Mehdi M.Z., Azar Z.M., Srivastava A.K. Role of receptor and nonreceptor protein tyrosine kinases in H2O2-induced PKB and ERK1/2 signaling. Cell Biochem. Biophys. 2007, 47:1-10.
85. Lee J., Giordano S., Zhang J. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem. J. 2012, 441:523-540.
86. Huo Y.Y., Li G., Duan R.F., Gou Q., Fu C.L., et al. PTEN deletion leads to deregulation of antioxidants and increased oxidative damage in mouse embryonic fibroblasts. Free Radical Biol. Med. 2008, 44:1578-1591.
87. 2. Proc. Natl. Acad. Sci. USA 1997, 94:11233-11237.
88. Kazanietz M.G. Targeting protein kinase C and "non-kinase" phorbol ester receptors: emerging concepts and therapeutic implications. Biochim. Biophys. Acta 2005, 1754:296-304.
89. Konishi H., Yamauchi E., Taniguchi H., Yamamoto T., Matsuzaki H., et al. Phosphorylation sites of protein kinase C delta in H2O2-treated cells and its activation by tyrosine kinase in vitro. Proc. Natl. Acad. Sci. USA 2001, 98:6587-6592.
90. Qatanani M., Lazar M.A. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 2007, 21:1443-1455.
91. Ostman A., Frijhoff J., Sandin A., Bohmer F.D. Regulation of protein tyrosine phosphatases by reversible oxidation. J. Biochem. 2011, 150:345-356.
92. Lavrovsky Y., Chatterjee B., Clark R.A., Roy A.K. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp. Gerontol. 2000, 35:521-532.
93. Speciale A., Chirafisi J., Saija A., Cimino F. Nutritional antioxidants and adaptive cell responses: an update. Curr. Mol. Med. 2011, 11:770-789.
94. Tornatore L., Thotakura A.K., Bennett J., Moretti M., Franzoso G. The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation. Trends Cell Biol. 2012, 22:557-566.
95. Kamata H., Manabe T., Oka S., Kamata K., Hirata H. Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops. FEBS Lett. 2002, 519:231-237.
96. Jamaluddin M., Wang S., Boldogh I., Tian B., Brasier A.R. TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway. Cell. Signal. 2007, 19:1419-1433.
97. Matthews J.R., Kaszubska W., Turcatti G., Wells T.N., Hay R.T. Role of cysteine62 in DNA recognition by the P50 subunit of NF-kappa B. Nucl. Acids Res. 1993, 21:1727-1734.
98. Pineda-Molina E., Klatt P., Vazquez J., Marina A., Garcia de Lacoba M., et al. Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry 2001, 40:14134-14142.
99. Motohashi H., Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 2004, 10:549-557.
100. Baird L., Dinkova-Kostova A.T. The cytoprotective role of the Keap1-Nrf2 pathway. Arch. Toxicol. 2011, 85:241-272.
101. Dinkova-Kostova A.T., Holtzclaw W.D., Cole R.N., Itoh K., Wakabayashi N., et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. USA 2002, 99:11908-11913.
102. Jain A.K., Mahajan S., Jaiswal A.K. Phosphorylation and dephosphorylation of tyrosine 141 regulate stability and degradation of INrf2: a novel mechanism in Nrf2 activation. J. Biol. Chem. 2008, 283:17712-17720.
103. Ma Q., He X. Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol. Rev. 2012, 64:1055-1081.
104. Wakabayashi N., Itoh K., Wakabayashi J., Motohashi H., Noda S., et al. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 2003, 35:238-245.
105. Jiang T., Chen N., Zhao F., Wang X.J., Kong B., et al. High levels of Nrf2 determine chemoresistance in type II endometrial cancer. Cancer Res. 2010, 70:5486-5496.
106. Gorlach A., Kietzmann T. Superoxide and derived reactive oxygen species in the regulation of hypoxia-inducible factors. Methods Enzymol. 2007, 435:421-446.
107. Carrero P., Okamoto K., Coumailleau P., O'Brien S., Tanaka H., et al. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol. Cell. Biol. 2000, 20:402-415.
108. Lando D., Pongratz I., Poellinger L., Whitelaw M.L. A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1alpha and the HIF-like factor. J. Biol. Chem. 2000, 275:4618-4627.
109. Hagen T. Oxygen versus reactive oxygen in the regulation of HIF-1alpha: the balance tips. Biochem. Res. Int. 2012, 2012:436981.
110. Jokilehto T., Jaakkola P.M. The role of HIF prolyl hydroxylases in tumour growth. J. Cell. Mol. Med. 2010, 14:758-770.
111. Kobliakov V.A. Mechanisms of tumor promotion by reactive oxygen species. BiochemistryBiokhimiia 2010, 75:675-685.
112. Nytko K.J., Maeda N., Schlafli P., Spielmann P., Wenger R.H., et al. Vitamin C is dispensable for oxygen sensing in vivo. Blood 2011, 117:5485-5493.
113. Izquierdo-Alvarez A., Ramos E., Villanueva J., Hernansanz-Agustin P., Fernandez-Rodriguez R., et al. Differential redox proteomics allows identification of proteins reversibly oxidized at cysteine residues in endothelial cells in response to acute hypoxia. J. Proteom. 2012, 75:5449-5462.
114. Diebold I., Petry A., Hess J., Gorlach A. The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol. Biol. Cell 2010, 21:2087-2096.
115. Brunelle J.K., Bell E.L., Quesada N.M., Vercauteren K., Tiranti V., et al. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 2005, 1:409-414.
116. Bell E.L., Klimova T.A., Eisenbart J., Moraes C.T., Murphy M.P., et al. The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J. Cell Biol. 2007, 177:1029-1036.
117. Mansfield K.D., Guzy R.D., Pan Y., Young R.M., Cash T.P., et al. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab. 2005, 1:393-399.
118. Guzy R.D., Hoyos B., Robin E., Chen H., Liu L., et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 2005, 1:401-408.
119. Hamanaka R.B., Chandel N.S. Mitochondrial reactive oxygen species regulate hypoxic signaling. Curr. Opin. Cell Biol. 2009, 21:894-899.
120. Dimova E.Y., Michiels C., Kietzmann T. Kinases as upstream regulators of the HIF system: their emerging potential as anti-cancer drug targets. Curr. Pharm. Des. 2009, 15:3867-3877.
121. Gorlach A., Diebold I., Schini-Kerth V.B., Berchner-Pfannschmidt U., Roth U., et al. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ. Res. 2001, 89:47-54.
122. Richard D.E., Berra E., Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J. Biol. Chem. 2000, 275:26765-26771.
123. Fukuda R., Kelly B., Semenza G.L. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res. 2003, 63:2330-2334.
124. Wang F.S., Wang C.J., Chen Y.J., Chang P.R., Huang Y.T., et al. Ras induction of superoxide activates ERK-dependent angiogenic transcription factor HIF-1alpha and VEGF-A expression in shock wave-stimulated osteoblasts. J. Biol. Chem. 2004, 279:10331-10337.
125. Gao N., Jiang B.H., Leonard S.S., Corum L., Zhang Z., et al. p38 Signaling-mediated hypoxia-inducible factor 1alpha and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells. J. Biol. Chem. 2002, 277:45041-45048.
126. Kietzmann T., Jungermann K., Gorlach A. Regulation of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases. Thromb. Haemost. 2003, 89:666-673.
127. Frede S., Stockmann C., Freitag P., Fandrey J. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. Biochem. J. 2006, 396:517-527.
128. Tacchini L., De Ponti C., Matteucci E., Follis R., Desiderio M.A. Hepatocyte growth factor-activated NF-kappaB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines. Carcinogenesis 2004, 25:2089-2100.
129. Page E.L., Robitaille G.A., Pouyssegur J., Richard D.E. Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J. Biol. Chem. 2002, 277:48403-48409.
130. Diebold I., Djordjevic T., Hess J., Gorlach A. Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription. Thromb. Haemost. 2008, 100:1021-1028.
131. Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A.S., et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008, 453:807-811.
132. Bonello S., Zahringer C., BelAiba R.S., Djordjevic T., Hess J., et al. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler. Thromb. Vasc. Biol. 2007, 27:755-761.
133. van Uden P., Kenneth N.S., Rocha S. Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem. J. 2008, 412:477-484.
134. Gorlach A., Bonello S. The cross-talk between NF-kappaB and HIF-1: further evidence for a significant liaison. Biochem. J. 2008, 412:e17-e19.
135. Belaiba R.S., Bonello S., Zahringer C., Schmidt S., Hess J., et al. Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol. Biol. Cell. 2007, 18:4691-4697.
136. Diebold I., Petry A., Djordjevic T., Belaiba R.S., Fineman J., et al. Reciprocal regulation of Rac1 and PAK-1 by HIF-1alpha: a positive-feedback loop promoting pulmonary vascular remodeling. Antioxid. Redox Signal. 2010, 13:399-412.
137. Petry A., BelAiba R.S., Weitnauer M., Gorlach A. Inhibition of endothelial nitric oxyde synthase increases capillary formation via Rac1-dependent induction of hypoxia-inducible factor-1alpha and plasminogen activator inhibitor-1. Thromb. Haemost. 2012, 108:849-862.
138. Rudich A., Kanety H., Bashan N. Adipose stress-sensing kinases: linking obesity to malfunction. Trends Endocrinol. Metab. 2007, 18:291-299.
139. Hernansanz-Agustin P., Izquierdo-Alvarez A., Sanchez-Gomez F.J., Ramos E., Villa-Pina T., et al. Acute hypoxia produces a superoxide burst in cells. Free Radic. Biol. Med. 2014, 71:146-156.
140. Marshall C., Mamary A.J., Verhoeven A.J., Marshall B.E. Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. Am. J. Respir. Cell Mol. Biol. 1996, 15:633-644.
141. Abramov A.Y., Scorziello A., Duchen M.R. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J. Neurosci. 2007, 27:1129-1138.
142. Semenza G.L. HIF-1: upstream and downstream of cancer metabolism. Curr. Opin. Genet. Dev. 2010, 20:51-56.
143. Hervouet E., Cizkova A., Demont J., Vojtiskova A., Pecina P., et al. HIF and reactive oxygen species regulate oxidative phosphorylation in cancer. Carcinogenesis 2008, 29:1528-1537.
144. Hagen T., Taylor C.T., Lam F., Moncada S. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science 2003, 302:1975-1978.
145. Diebold I., Petry A., Sabrane K., Djordjevic T., Hess J., et al. The HIF1 target gene NOX2 promotes angiogenesis through urotensin-II. J. Cell Sci. 2012, 125:956-964.
146. Whaley-Connell A., Sowers J.R. Oxidative stress in the cardiorenal metabolic syndrome. Curr. Hypertens. Rep. 2012, 14:360-365.
147. Costford S.R., Castro-Alves J., Chan K.L., Bailey L.J., Woo M., et al. Mice lacking NOX2 are hyperphagic and store fat preferentially in the liver. Am. J. Physiol. Endocrinol. Metab. 2014, 306:E1341-E1353.
148. Kim J.W., Tchernyshyov I., Semenza G.L., Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006, 3:177-185.
149. Papandreou I., Cairns R.A., Fontana L., Lim A.L., Denko N.C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 2006, 3:187-197.
150. Lu C.W., Lin S.C., Chen K.F., Lai Y.Y., Tsai S.J. Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance. J. Biol. Chem. 2008, 283:28106-28114.
151. Lee J.H., Kim E.J., Kim D.K., Lee J.M., Park S.B., et al. Hypoxia induces PDK4 gene expression through induction of the orphan nuclear receptor ERRgamma. PLoS One 2012, 7:e46324.
152. Zhong L., D'Urso A., Toiber D., Sebastian C., Henry R.E., et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 2010, 140:280-293.
153. Tello D., Balsa E., Acosta-Iborra B., Fuertes-Yebra E., Elorza A., et al. Induction of the mitochondrial NDUFA4L2 protein by HIF-1alpha decreases oxygen consumption by inhibiting Complex I activity. Cell Metab. 2011, 14:768-779.
154. Chan S.Y., Zhang Y.Y., Hemann C., Mahoney C.E., Zweier J.L., et al. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab. 2009, 10:273-284.
155. Fukuda R., Zhang H., Kim J.W., Shimoda L., Dang C.V., et al. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 2007, 129:111-122.
156. Horak P., Crawford A.R., Vadysirisack D.D., Nash Z.M., DeYoung M.P., et al. Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc. Natl. Acad. Sci. USA 2010, 107:4675-4680.
157. Scortegagna M., Ding K., Oktay Y., Gaur A., Thurmond F., et al. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat. Genet. 2003, 35:331-340.
158. Izquierdo-Alvarez A., Martinez-Ruiz A. Thiol redox proteomics seen with fluorescent eyes: the detection of cysteine oxidative modifications by fluorescence derivatization and 2-DE. J. Proteom. 2011, 75:329-338.
159. Martinez-Acedo P., Nunez E., Gomez F.J., Moreno M., Ramos E., et al. A novel strategy for global analysis of the dynamic thiol redox proteome. Mol. Cell. Proteom. 2012, 11:800-813.
160. Baena Ruiz R., Salinas Hernandez P. Diet and cancer: risk factors and epidemiological evidence. Maturitas 2014, 77:202-208.
161. Hammes H.P., Du X., Edelstein D., Taguchi T., Matsumura T., et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat. Med. 2003, 9:294-299.
162. Rolo A.P., Palmeira C.M. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol. 2006, 212:167-178.
163. Teodoro J.S., Gomes A.P., Varela A.T., Duarte F.V., Rolo A.P., et al. Uncovering the beginning of diabetes: the cellular redox status and oxidative stress as starting players in hyperglycemic damage. Mol. Cell. Biochem. 2013, 376:103-110.
164. Vallim T., Salter A.M. Regulation of hepatic gene expression by saturated fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 2010, 82:211-218.
165. Bagi Z., Koller A., Kaley G. PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H742-H748.
166. Garcia-Fuentes E., Murri M., Garrido-Sanchez L., Garcia-Serrano S., Garcia-Almeida J.M., et al. PPARgamma expression after a high-fat meal is associated with plasma superoxide dismutase activity in morbidly obese persons. Obesity (Silver Spring, Md) 2010, 18:952-958.
167. Krishnan J., Suter M., Windak R., Krebs T., Felley A., et al. Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metab. 2009, 9:512-524.
168. Ghibaudi L., Cook J., Farley C., van Heek M., Hwa J.J. Fat intake affects adiposity, comorbidity factors, and energy metabolism of sprague-dawley rats. Obes. Res. 2002, 10:956-963.
169. Johnston S.L., Souter D.M., Tolkamp B.J., Gordon I.J., Illius A.W., et al. Intake compensates for resting metabolic rate variation in female C57BL/6J mice fed high-fat diets. Obesity (Silver Spring) 2007, 15:600-606.
170. Samuel V.T., Liu Z.X., Qu X., Elder B.D., Bilz S., et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J. Biol. Chem. 2004, 279:32345-32353.
171. 2 consumption triggers HIF-1alpha, causing inflammation and insulin resistance in obesity. Cell 2014, 157:1339-1352.
172. Hussein O., Grosovski M., Lasri E., Svalb S., Ravid U., et al. Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats. World J. Gastroenterol. 2007, 13:361-368.
173. Lee G.S., Yan J.S., Ng R.K., Kakar S., Maher J.J. Polyunsaturated fat in the methionine-choline-deficient diet influences hepatic inflammation but not hepatocellular injury. J. Lipid Res. 2007, 48:1885-1896.
174. Daly M.E., Vale C., Walker M., Alberti K.G., Mathers J.C. Dietary carbohydrates and insulin sensitivity: a review of the evidence and clinical implications. Am. J. Clin. Nutr. 1997, 66:1072-1085.
175. Basciano H., Federico L., Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr. Metab. (Lond.) 2005, 2:5.
176. Sahai A., Malladi P., Melin-Aldana H., Green R.M., Whitington P.F. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287:G264-G273.
177. Weltman M.D., Farrell G.C., Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 1996, 111:1645-1653.
178. Pickens M.K., Ogata H., Soon R.K., Grenert J.P., Maher J.J. Dietary fructose exacerbates hepatocellular injury when incorporated into a methionine-choline-deficient diet. Liver Int. 2010, 30:1229-1239.
179. Teodoro J.S., Rolo A.P., Duarte F.V., Simoes A.M., Palmeira C.M. Differential alterations in mitochondrial function induced by a choline-deficient diet: understanding fatty liver disease progression. Mitochondrion 2008, 8:367-376.
180. Fujita K., Nozaki Y., Yoneda M., Wada K., Takahashi H., et al. Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model. Alcohol Clin. Exp. Res. 2010, 34(Suppl 1):S18-S24.
181. Takeuchi-Yorimoto A., Noto T., Yamada A., Miyamae Y., Oishi Y., et al. Persistent fibrosis in the liver of choline-deficient and iron-supplemented l-amino acid-defined diet-induced nonalcoholic steatohepatitis rat due to continuing oxidative stress after choline supplementation. Toxicol. Appl. Pharmacol. 2013, 268:264-277.
182. Curtis J.M., Hahn W.S., Long E.K., Burrill J.S., Arriaga E.A., et al. Protein carbonylation and metabolic control systems. Trends Endocrinol. Metab. 2012, 23:399-406.
183. Anderson E.J., Lustig M.E., Boyle K.E., Woodlief T.L., Kane D.A., et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J. Clin. Invest. 2009, 119:573-581.
184. Ruggiero C., Ehrenshaft M., Cleland E., Stadler K. High-fat diet induces an initial adaptation of mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ROS production. Am. J. Physiol. Endocrinol. Metab. 2011, 300:E1047-E1058.
185. Raffaella C., Francesca B., Italia F., Marina P., Giovanna L., et al. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance. Obesity (Silver Spring) 2008, 16:958-964.
186. Curtis J.M., Grimsrud P.A., Wright W.S., Xu X., Foncea R.E., et al. Downregulation of adipose glutathione S-transferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction. Diabetes 2010, 59:1132-1142.
187. Sarna L.K., Wu N., Wang P., Hwang S.Y., Siow Y.L., et al. Folic acid supplementation attenuates high fat diet induced hepatic oxidative stress via regulation of NADPH oxidase. Can. J. Physiol. Pharmacol. 2012, 90:155-165.
188. Abreu I.C., Guerra J.F., Pereira R.R., Silva M., Lima W.G., et al. Hypercholesterolemic diet induces hepatic steatosis and alterations in mRNA expression of NADPH oxidase in rat livers. Arq. Bras. Endocrinol. Metabol. 2014, 58:251-259.
189. Ronis M.J., Sharma N., Vantrease J., Borengasser S.J., Ferguson M., et al. Female mice lacking p47phox have altered adipose tissue gene expression and are protected against high fat-induced obesity. Physiol. Genom. 2013, 45:351-366.
190. Pepping J.K., Freeman L.R., Gupta S., Keller J.N., Bruce-Keller A.J. NOX2 deficiency attenuates markers of adiposopathy and brain injury induced by high-fat diet. Am. J. Physiol. Endocrinol. Metab. 2013, 304:E392-E404.
191. Li N., Li B., Brun T., Deffert-Delbouille C., Mahiout Z., et al. NADPH oxidase NOX2 defines a new antagonistic role for reactive oxygen species and cAMP/PKA in the regulation of insulin secretion. Diabetes 2012, 61:2842-2850.
192. Souto Padron de Figueiredo A., Salmon A.B., Bruno F., Jimenez F., Martinez H.G., et al. Nox2 mediates skeletal muscle insulin resistance induced by a high fat diet. J. Biol. Chem. 2015, 290:13427-13439.
193. Paglialunga S., Ludzki A., Root-McCaig J., Holloway G.P. In adipose tissue, increased mitochondrial emission of reactive oxygen species is important for short-term high-fat diet-induced insulin resistance in mice. Diabetologia 2015, 58:1071-1080.
194. Diebold I., Flugel D., Becht S., Belaiba R.S., Bonello S., et al. The hypoxia-inducible factor-2alpha is stabilized by oxidative stress involving NOX4. Antioxid. Redox Signal. 2010, 13:425-436.
195. Anavi S., Hahn-Obercyger M., Madar Z., Tirosh O. Mechanism for HIF-1 activation by cholesterol under normoxia: A redox signaling pathway for liver damage. Free Radic. Biol. Med. 2014, 71:61-69.
196. Girgis C.M., Cheng K., Scott C.H., Gunton J.E. Novel links between HIFs, type 2 diabetes, and metabolic syndrome. Trends Endocrinol. Metab. 2012, 23:372-380.
197. Qu A., Taylor M., Xue X., Matsubara T., Metzger D., et al. Hypoxia-inducible transcription factor 2alpha promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis. Hepatology 2011, 54:472-483.
198. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
199. Russell S.J., Kahn C.R. Endocrine regulation of ageing. Nat. Rev. Mol. Cell Biol. 2007, 8:681-691.
200. Kahn B.B., Flier J.S. Obesity and insulin resistance. J. Clin. Invest. 2000, 106:473-481.
201. Mazumder P.K., O'Neill B.T., Roberts M.W., Buchanan J., Yun U.J., et al. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 2004, 53:2366-2374.
202. Buchanan J., Mazumder P.K., Hu P., Chakrabarti G., Roberts M.W., et al. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 2005, 146:5341-5349.
203. How O.J., Aasum E., Severson D.L., Chan W.Y., Essop M.F., et al. Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 2006, 55:466-473.
204. Boudina S., Sena S., O'Neill B.T., Tathireddy P., Young M.E., et al. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 2005, 112:2686-2695.
205. Niemann B., Chen Y., Teschner M., Li L., Silber R.E., et al. Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria. J. Am. Coll. Cardiol. 2011, 57:577-585.
206. Sloan C., Tuinei J., Nemetz K., Frandsen J., Soto J., et al. Central leptin signaling is required to normalize myocardial fatty acid oxidation rates in caloric-restricted ob/ob mice. Diabetes 2011, 60:1424-1434.
207. Liang L., Shou X.L., Zhao H.K., Ren G.Q., Wang J.B., et al. Antioxidant catalase rescues against high fat diet-induced cardiac dysfunction via an IKKbeta-AMPK-dependent regulation of autophagy. Biochim. Biophys. Acta 2015, 1852:343-352.
208. Dodson M., Darley-Usmar V., Zhang J. Cellular metabolic and autophagic pathways: traffic control by redox signaling. Free Radic. Biol. Med. 2013, 63:207-221.
209. Barbosa I.A., Machado N.G., Skildum A.J., Scott P.M., Oliveira P.J. Mitochondrial remodeling in cancer metabolism and survival: potential for new therapies. Biochim. Biophys. Acta 2012, 1826:238-254.
210. Bertram K., Valcu C.M., Weitnauer M., Linne U., Gorlach A. NOX1 supports the metabolic remodeling of HepG2 cells. PLoS One 2015, 10:e0122002.
211. Stiehl D.P., Jelkmann W., Wenger R.H., Hellwig-Burgel T. Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway. FEBS Lett. 2002, 512:157-162.
212. Treins C., Giorgetti-Peraldi S., Murdaca J., Semenza G.L., Van Obberghen E. Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J. Biol. Chem. 2002, 277:27975-27981.
213. Kietzmann T., Samoylenko A., Roth U., Jungermann K. Hypoxia-inducible factor-1 and hypoxia response elements mediate the induction of plasminogen activator inhibitor-1 gene expression by insulin in primary rat hepatocytes. Blood 2003, 101:907-914.
214. Semenza G.L. HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J. Clin. Invest. 2013, 123:3664-3671.
215. Jungermann K., Kietzmann T. Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 2000, 31:255-260.
216. Rankin E.B., Rha J., Selak M.A., Unger T.L., Keith B., et al. Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol. Cell. Biol. 2009, 29:4527-4538.
217. Taniguchi C.M., Finger E.C., Krieg A.J., Wu C., Diep A.N., et al. Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes. Nat. Med. 2013, 19:1325-1330.
218. Furuta E., Pai S.K., Zhan R., Bandyopadhyay S., Watabe M., et al. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res. 2008, 68:1003-1011.
219. Kamphorst J.J., Cross J.R., Fan J., de Stanchina E., Mathew R., et al. Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc. Natl. Acad. Sci. USA 2013, 110:8882-8887.
220. Valli A., Rodriguez M., Moutsianas L., Fischer R., Fedele V., et al. Hypoxia induces a lipogenic cancer cell phenotype via HIF1alpha-dependent and -independent pathways. Oncotarget 2015, 6:1920-1941.
221. Zhao T., Zhu Y., Morinibu A., Kobayashi M., Shinomiya K., et al. HIF-1-mediated metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of cancers in lungs. Sci. Rep. 2014, 4:3793.
222. Diehn M., Cho R.W., Lobo N.A., Kalisky T., Dorie M.J., et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009, 458:780-783.
223. Nogueira V., Hay N. Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clin. Cancer Res. 2013, 19:4309-4314.
224. Rao V.A., Klein S.R., Bonar S.J., Zielonka J., Mizuno N., et al. The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinone. J. Biol. Chem. 2010, 285:34447-34459.
225. Gonzalez Y., Aryal B., Chehab L., Rao V.A. Atg7- and Keap1-dependent autophagy protects breast cancer cell lines against mitoquinone-induced oxidative stress. Oncotarget 2014, 5:1526-1537.
226. Gozuacik D., Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004, 23:2891-2906.
227. Chen Y., Wei H., Liu F., Guan J.L. Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) promotes breast cancer progression through enhancing glucose starvation-induced autophagy and Akt signaling. J. Biol. Chem. 2014, 289:1164-1173.
228. Menon S., Manning B.D. Common corruption of the mTOR signaling network in human tumors. Oncogene 2008, 27(Suppl 2):S43-S51.
229. Laplante M., Sabatini D.M. mTOR signaling at a glance. J. Cell Sci. 2009, 122:3589-3594.
230. Mates J.M., Segura J.A., Alonso F.J., Marquez J. Oxidative stress in apoptosis and cancer: an update. Arch. Toxicol. 2012, 86:1649-1665.
231. Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Meyskens F.L., et al. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J. Natl. Cancer Inst. 2004, 96:1743-1750.
232. Samoylenko A., Hossain J.A., Mennerich D., Kellokumpu S., Hiltunen J.K., et al. Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence. Antioxid. Redox Signal. 2013, 19:2157-2196.
233. Myung S.K., Kim Y., Ju W., Choi H.J., Bae W.K. Effects of antioxidant supplements on cancer prevention: meta-analysis of randomized controlled trials. Ann. Oncol. 2010, 21:166-179.
234. Halliwell B. The antioxidant paradox. Lancet 2000, 355:1179-1180.
235. Hollman P.C., Cassidy A., Comte B., Heinonen M., Richelle M., et al. The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J. Nutr. 2011, 141:989S-1009S.
236. Sheikh-Ali M., Chehade J.M., Mooradian A.D. The antioxidant paradox in diabetes mellitus. Am. J. Ther. 2011, 18:266-278.
237. Miller E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 2005, 142:37-46.
238. Hopkins M.H., Fedirko V., Jones D.P., Terry P.D., Bostick R.M. Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial. Cancer Epidemol. Biomarkers Prev. 2010, 19:850-858.
239. Mayne S.T., Handelman G.J., Beecher G. Beta-Carotene and lung cancer promotion in heavy smokers--a plausible relationship?. J. Natl. Cancer Inst. 1996, 88:1513-1515.
240. Vargas A.J., Burd R. Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management. Nutr. Rev. 2010, 68:418-428.
241. Schmidt H.H., Stocker R., Vollbracht C., Paulsen G., Riley D.P., et al. Antioxidants in Translational Medicine. Antioxid. Redox Signal. 2015.
242. Agudo A., Cabrera L., Amiano P., Ardanaz E., Barricarte A., et al. Fruit and vegetable intakes, dietary antioxidant nutrients, and total mortality in Spanish adults: findings from the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain). Am. J. Clin. Nutr. 2007, 85:1634-1642.
243. Kirsh V.A., Peters U., Mayne S.T., Subar A.F., Chatterjee N., et al. Prospective study of fruit and vegetable intake and risk of prostate cancer. J. Natl. Cancer Inst. 2007, 99:1200-1209.
244. Zhang C.X., Ho S.C., Chen Y.M., Fu J.H., Cheng S.Z., et al. Greater vegetable and fruit intake is associated with a lower risk of breast cancer among Chinese women. Int. J. Cancer 2009, 125:181-188.
245. Liu R.H. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J. Nutr. 2004, 134:3479S-3485S.
246. Karlsen A., Svendsen M., Seljeflot I., Sommernes M.A., Sexton J., et al. Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers. Br. J. Nutr. 2011, 106:557-571.
247. Simopoulos A.P. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. (Maywood, NJ) 2008, 233:674-688.